Report Search Results	As of 23-Nov-2009
New Screen

All Reports | Brokerage Reports | Independent Reports

All Reports (Showing 1 to 10 of 30) Release Date  Contributor Author Title Pages Price StarMine Author Rating More Info EPS Accuracy * Portfolio Return ** 23-Nov-09 Market Edge N/A Market Edge Equity Research Report 4 $10     View Abstract 20-Nov-09 New Constructs, LLC N/A UTHR: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings 19 $10     View Abstract 20-Nov-09 Pechala's Reports Lubomir Pechala UNITED THERAPEUTICS CORPORATION (UTHR=US) - REPORT FOR ACTIVE TRADERS 4 $25     View Abstract 20-Nov-09 ValuEngine, Inc. N/A ValuEngine Industry Report for DRUGS 18 $49     View Abstract 20-Nov-09 Ford Investor Services, Inc. N/A Value Graph: UNITED THERAPEUT -- UTHR 1 $4     View Abstract 20-Nov-09 Jefferson Research N/A Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of UNITED THERAPEUTICS CORP including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation. 3 $20     View Abstract 20-Nov-09 Ford Investor Services, Inc. N/A Industry Value Graph: ALKS , HITK , LGND , PANC , PPCO , UTHR -- DRUGS 3 $4     View Abstract 17-Nov-09 EconomicInvestor N/A "The Economy Matters" Report for UTHR: the economy's impact on UTHR's price and risk, featuring the powerful EconomicInvestor Star Rating 6 $15     View Abstract 16-Nov-09 ValuEngine, Inc. N/A ValuEngine Detailed Valuation Report for UTHR 13 $25     View Abstract 16-Nov-09 PriceTarget Research, Inc. N/A UTHR has a current Overall Rating of B (Positive). 7 $25     View Abstract Next 20

Brokerage Reports (Showing 1 to 4 of 4) Release Date  Contributor Author Title Pages Price StarMine Author Rating More Info EPS Accuracy * Portfolio Return ** 31-Oct-09 Thomson StreetEvents N/A UTHR - Event Transcript of United Therapeutics conference call, Oct. 29, 2009 / 9:00am ET 14 $75     View Abstract 31-Oct-09 Thomson StreetEvents N/A UTHR - Event Brief of United Therapeutics conference call, Oct. 29, 2009 / 9:00am ET 14 $75     View Abstract 29-Oct-09 Collins Stewart LLC Salveen J. Kochnover CFA 3Q09 EPS; Top-Line Growth Impresses 7 $25     View Abstract 29-Oct-09 Brean Murray & Co., Inc. Jonathan M. Aschoff PhD UTHR: Reports Record Revenue; Expecting Strong Top-Line Growth in 2010 4 $10     View Abstract

Independent Reports (Showing 1 to 10 of 26) Release Date  Contributor Author Title Pages Price More Info 23-Nov-09 Market Edge N/A Market Edge Equity Research Report 4 $10 View Abstract 20-Nov-09 New Constructs, LLC N/A UTHR: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings 19 $10 View Abstract 20-Nov-09 Pechala's Reports Lubomir Pechala UNITED THERAPEUTICS CORPORATION (UTHR=US) - REPORT FOR ACTIVE TRADERS 4 $25 View Abstract 20-Nov-09 ValuEngine, Inc. N/A ValuEngine Industry Report for DRUGS 18 $49 View Abstract 20-Nov-09 Ford Investor Services, Inc. N/A Value Graph: UNITED THERAPEUT -- UTHR 1 $4 View Abstract 20-Nov-09 Jefferson Research N/A Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of UNITED THERAPEUTICS CORP including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation. 3 $20 View Abstract 20-Nov-09 Ford Investor Services, Inc. N/A Industry Value Graph: ALKS , HITK , LGND , PANC , PPCO , UTHR -- DRUGS 3 $4 View Abstract 17-Nov-09 EconomicInvestor N/A "The Economy Matters" Report for UTHR: the economy's impact on UTHR's price and risk, featuring the powerful EconomicInvestor Star Rating 6 $15 View Abstract 16-Nov-09 ValuEngine, Inc. N/A ValuEngine Detailed Valuation Report for UTHR 13 $25 View Abstract 16-Nov-09 PriceTarget Research, Inc. N/A UTHR has a current Overall Rating of B (Positive). 7 $25 View Abstract Next 16